EE494 A Budget Impact Analysis of Newer Pneumococcal Conjugate Vaccine Use in All US Adults Aged 50-64 Years Old Compared to Current Recommendations from US Payer Perspective
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2258
https://www.valueinhealthjournal.com/article/S1098-3015(24)02472-0/fulltext
Title :
EE494 A Budget Impact Analysis of Newer Pneumococcal Conjugate Vaccine Use in All US Adults Aged 50-64 Years Old Compared to Current Recommendations from US Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02472-0&doi=10.1016/j.jval.2024.03.2258
First page :
Section Title :
Open access? :
No
Section Order :
10249